← Back to Search

Other

TearCare for Dry Eye Syndrome

N/A
Waitlist Available
Research Sponsored by Sight Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with dry eye disease
Signs and symptoms of dry eye disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This study is being conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease. NOTE: All sites have been selected for this study.

Eligible Conditions
  • Dry Eye Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Tear Break-up time from baseline to 1 month
Secondary outcome measures
Change in Conjunctival staining score from baseline to 1 month
Change in Cornea staining score from baseline to 1 month
Change in Meibomian gland secretion score from baseline to 1 month
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: TearCareExperimental Treatment1 Intervention
All subjects in the study will undergo the TearCare procedure one time at the baseline visit. They will then be followed out to one month.

Find a Location

Who is running the clinical trial?

Sight Sciences, Inc.Lead Sponsor
12 Previous Clinical Trials
985 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Mar 2025